We are live on ! Find out more
MA

Montag & Associates Portfolio holdings

AUM $2.15B
1-Year Est. Return 20.86%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+20.86%
3 Year Est. Return
+68%
5 Year Est. Return
+82.09%
10 Year Est. Return
+321.81%
AUM
$613M
AUM Growth
+$21.7M
Cap. Flow
-$3.21M
Cap. Flow %
-0.52%
Top 10 Hldgs %
22.48%
Holding
251
New
18
Increased
52
Reduced
87
Closed
9

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$4.1M
2
LLY icon
Eli Lilly
LLY
+$3.04M
3
INGR icon
Ingredion
INGR
+$2.73M
4
CSCO icon
Cisco
CSCO
+$2.62M
5
TDW icon
Tidewater
TDW
+$2.35M

Sector Composition

Rank Sector Weight
1 Healthcare 12.05%
2 Financials 10.79%
3 Industrials 9.01%
4 Consumer Staples 8.86%
5 Technology 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDY icon
1
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$31.5M 5.14%
120,897
+637
+0.5% +$159K
SPY icon
2
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$22.9M 3.73%
116,910
-3,369
-3% -$641K
KO icon
3
Coca-Cola
KO
$354B
$13.7M 2.23%
322,242
-31,674
-9% -$1.29M
VGK icon
4
Vanguard FTSE Europe ETF
VGK
$30B
$12.9M 2.11%
215,426
+15,862
+8% +$955K
AIG icon
5
American International
AIG
$41.9B
$11M 1.79%
201,485
+5,780
+3% +$306K
IVV icon
6
iShares Core S&P 500 ETF
IVV
$876B
$9.51M 1.55%
48,279
+3,678
+8% +$704K
VMC icon
7
Vulcan Materials
VMC
$36.3B
$9.41M 1.53%
147,690
+3,372
+2% +$213K
JNJ icon
8
Johnson & Johnson
JNJ
$635B
$8.94M 1.46%
85,450
+205
+0.2% +$20.7K
GOOG icon
9
Alphabet (Google) Class C
GOOG
$3.9T
$8.85M 1.44%
306,178
+52,832
+21% +$1.43M
IBM icon
10
IBM
IBM
$202B
$8.5M 1.39%
49,042
-5,466
-10% -$984K
IWB icon
11
iShares Russell 1000 ETF
IWB
$47.7B
$8.33M 1.36%
75,660
GE icon
12
GE Aerospace
GE
$367B
$8.32M 1.36%
66,075
+430
+0.7% +$54.7K
EFX icon
13
Equifax
EFX
$20.3B
$8.31M 1.35%
114,519
-150
-0.1% -$10.5K
WBA
14
DELISTED
Walgreens Boots Alliance
WBA
$8.25M 1.35%
111,310
-855
-0.8% -$59.7K
SPB icon
15
Spectrum Brands
SPB
$2.04B
$8.05M 1.31%
93,580
-20,080
-18% -$1.57M
VIG icon
16
Vanguard Dividend Appreciation ETF
VIG
$111B
$7.99M 1.3%
102,531
+613
+0.6% +$46.9K
ESRX
17
DELISTED
Express Scripts Holding Company
ESRX
$7.85M 1.28%
113,164
-4,330
-4% -$305K
HD icon
18
Home Depot
HD
$332B
$6.9M 1.12%
85,175
+200
+0.2% +$15.8K
SWKS icon
19
Skyworks Solutions
SWKS
$9.06B
$6.79M 1.11%
144,681
-43,729
-23% -$1.84M
HOUS
20
DELISTED
Anywhere Real Estate
HOUS
$6.46M 1.05%
171,320
-16,720
-9% -$649K
VO icon
21
Vanguard Mid-Cap ETF
VO
$106B
$6.23M 1.02%
209,844
+72
+0% +$2.06K
KMX icon
22
CarMax
KMX
$8.27B
$6.21M 1.01%
119,485
+4,680
+4% +$213K
MAR icon
23
Marriott International
MAR
$98.7B
$5.91M 0.96%
92,244
ADBE icon
24
Adobe
ADBE
$89.5B
$5.88M 0.96%
81,205
-3,805
-4% -$245K
RSP icon
25
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$5.86M 0.96%
76,439
-24,375
-24% -$1.81M

Similar funds

Montag & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Montag & Associates held 251 positions worth $613M, up 3.7% from $592M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Montag & Associates's Q2 2014 filing shows 18 new, 52 increased, 87 reduced and 9 closed positions. Its largest new stake was Gilead Sciences: 52,627 shares worth $4.36M. The largest sale was CF Industries, an estimated $4.8M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • Montag & Associates's largest Q2 2014 buy was Gilead Sciences: 52,627 shares worth $4.36M.
  • Montag & Associates added most to Eli Lilly in Q2 2014, an estimated $3.04M increase.
  • Montag & Associates's biggest Q2 2014 reduction was Huntington Ingalls Industries, cutting an estimated $3.97M.
  • Montag & Associates fully exited CF Industries in Q2 2014, selling an estimated $4.8M.
  • Montag & Associates's ten largest holdings make up 22% of its $613M portfolio in Q2 2014.
  • Montag & Associates opened 18 new positions and closed 9 in Q2 2014.
  • Montag & Associates's portfolio value rose 3.7% quarter-over-quarter to $613M.

Based on Montag & Associates's 13F filing for Q2 2014, filed 6 Aug 2014.